Antigens and infectious agents that stimulate interferon ot(IFN-t~) production in mice induce antibody responses that are predominantly of the immunoglobulin (Ig)G2a isotype and contain little or no IgE. This suggested the possibility that IFN-ot might have a role in directing Ig isotype selection. Consistent with this possibility, we have found that injection of mice with recombinant mouse IFN-ol suppresses IgE secretion, enhances IgG2a secretion, and has no independent effect on IgG1 secretion in mice stimulated with a foreign anti-IgD antibody. Injection of mice with polyinosinic acid.polycytidylic acid (poly I.C), an inducer of macrophage IFN-ol production, also suppresses the anti-IgD antibody-induced IgE response and stimulates the IgG2a response; these effects are blocked by a sheep antibody that neutralizes mouse IFN-oL//~ Both recombinant IFN-c~ and poly I-C have maximum IgE suppressive and IgG2a stimulatory effects when injected early in the anti-IgD antibody-induced immune response. Addition of IFN-ot to mouse B cells cultured with lipopolysaccharide (LPS) + interleukin 4(I1,4) suppresses both IgG1 and IgE production, but much less potently than IFN-% IFN-c~ suppresses anti-IgD antibodyinduced increases in the level of splenic I1,4 mRNA, but enhances the anti-IgD antibody-induced increase in the splenic level of IFN-3' mRNA. These results are consistent with the effect of IFN-o~ on Ig isotype expression in mice, as I1,4 stimulates IgE and suppresses IgG2a secretion while IFN-3" exerts opposite effects. These observations suggest that antigen presenting cells, by secreting IFN-oe early in the course of an immune response, can influence the nature of that response both through direct effects on B cells and by influencing the differentiation of T cells.
D
ifferential production of cytokines during an immune response has important regulatory effects on the nature of that response. Responses in mice that are characterized by substantial II.-4 but little IFN-3' production generate IgG1-and IgE-secreting cells, with little IgG2a (1, 2). Responses in which the production of IFN-~' predominates are characterized by IgG2a production, activation of macrophages to kill intracellular parasites, delayed type hypersensitivity, and little or no IgE production (2) (3) (4) (5) (6) (7) .
The correlations between cytokine production and selection of Ig isotypes in large part reflect direct effects of I1,4 and IFN-3, on B lymphocytes. In the presence of bacterial LPS, IL-4 stimulates purified B cells to secrete IgG1 and IgE, and suppresses IgG2a production, while IFN-3~ has the opposite effect (8) (9) (10) (11) . Furthermore, anti-I1,4 antibody blocks IgE responses and can enhance IgG2a responses in vivo (12, 13) . IFN-3' has the same effects and also inhibits production in vivo of IgG1, and anti-IFN-3, antibody can enhance production in vivo of IgG1 and IgE and inhibit the production of IgG2a (7) .
Cytokines, however, may also have indirect effects on Ig isotype selection. Mouse CD4 § T cell clones prepared after longterm immune stimulation tend to produce exclusively either of two sets of cytokines. Thl cells secrete I1,2, IFN-3', and lymphotoxin, but not Ib4, Ib5, I1,6, or II,10, while Th2 cells have the opposite cytokine secretory profile (3, 4, 14) . IFN-3~ inhibits the proliferation of Th2, but not Thl cells (15) , while I1,10 inhibits cytokine secretion by Thl, but not Th2 cells (16) . Thus, once one CD4 + T cell subset becomes dominant during an immune response, a mechanism exists to maintain that dominance. The mechanisms by which resting CD4 + T cells are induced during activation to differentiate into cells that secrete predominantly Thl or Th2 cytokines are less clear. One possibility is that non-T cells might be stimulated early in an immune response to produce factors that can influence T cell differentiation.
IFN-c~ is an attractive candidate for a cytokine that might influence the characteristics of an immune response both through direct actions on effector cells and through the regulation of T cell differentiation. Large quantities of IFN-ol are produced early in some immune responses by macrophages (17) . Thus, macrophages might simultaneously present antigen to T cells, activating them, and influence their pathway of differentiation by secreting IFN-ot. Second, IFN-ol, like IFN-% inhibits IgE production by human PBCs that are cultured with IL-4 (18) . Third, the injection of mice with killed, fixed, Brucella abortus (BA), ~ an agent known to stimulate the production of both IFN-y and IFN-ot (7, 19, 20) , blocks the generation of both IgG1 and IgE responses in vivo (7) . Administration of anti-IFN-y antibody to these mice blocks the inhibitory effect of BA on IgG1 production, but fails to block its inhibitory effect on IgE production (7). We hypothesized that the production of IFN-o~ in response to BA might be responsible for this IFN-3,-independent effect.
To investigate the possible role of IFN-c~ in the regulation of Ig isotype secretion we have studied the effects of recombinant IFN-ot, agents that induce endogenous IFN-cr production, and a polyclonal anti-IFN-od/~ antibody on the Ig isotypes secreted in mice that have been stimulated to make a large polyclonal Ig response by the injection of anti-IgD antibodies. These studies provide evidence that IFN-o~ produced early in the course of an immune response inhibits IgE production and stimulates IgG2a production, and that these effects may result from a decrease in T cell IL-4 gene expression as well as from a direct effect on the B cell.
Materials and Methods
Animals. BALB/c female mice were purchased from the Small Animals Division of the National Cancer Institute, NIH, and were used at 8 to 12 wk-of-age. The experiments herein were conducted according to the principles set forth in the Guide for the Care and Use of Laboratory Animals, Institute of Animal Resources, National Research Council, Department of Health, Education and Welfare Publication (National Institutes of Health) 78-23.
Antibodies. The following antibodies were prepared as described: affinity purified goat anti-mouse IgD (GaMe5) (21); FF1-4D5 (a mouse IgG2a mAb of the b allotype specific for IgD of the a allotype) (22) ; H/~ ~ 1 (a mouse IgG2b mAb of the b allotype specific for IgD of the a allotype) (23); XMG-6 (a rat IgG1 that neutralizes mouse IFN-3') (24); J4-1 (a rat IgG1 anti-NP mAb, used as a control) (23); 24G2 (a rat IgG2b antibody specific for the mouse Fc3,1LII ) (25); a polyclonal sheep antibody that neutralizes mouse IFN-c~ and IFN-/~ (SalFN-od/3) (26); and normal sheep serum.
t Abbreviations used this paper: BA, Brucella abortus; GaMS, affinity-purified goat antibody specific for IgD; HPRT, hypoxanthine-guanine phosphoribosyl transferase; MaMa, a combination of two mouse aUoantibodies specific for mouse IgD; poly I.C, polyinosinic acid.polycytidylic acid.
Immune Reagents. Recombinant murine IFN-ot, generously provided by Schering-Plough Research (Bloomfield, NJ), was diluted in 0.5 M NaC1/0.02 M Tris, pH 7.4, and kept frozen at -70~ until used. Different lots had 0.85-1.7 x 107 IU/mg of antiviral activity. All lots were free of detectable LPS by the limulus assay. Recombinant mouse IL-4 (a gift of Dr. William E. Paul, Bethesda, MD) was produced in the baculovirus system and purified by passage over an anti-IL-4 (11Bll) (27) affinity column, followed by further purification by HPLC. Ib4 was quantitated with a CT.4S proliferation assay (28) . Polyinosinic acid-polycytidylic acid (poly I.C) was purchased from Boehringer Mannheim Biochemicals (Indianapolis, IN). Lipopolysaccharide (LPS W, extracted from Escherichia coli 0111:B4) was purchased from Difco Laboratories, Inc. (Detroit, MI).
Cell Cultures. Enriched populations of B cells were obtained from BALB/c spleens by treatment with anti-Thy 1 (mAb 30H12) (29) plus complement. Small dense B cells were obtained by discontinuous Percoll gradient centrifugation. Cells that formed a band between 60% and 70% Percoll and had a density of 1.081-1.086 g/ml were considered to be resting B cells. Cells were cultured for 6 d at 1.25 x 105 cells/ml in 6-well flat-bottom Costar plates (Costar, Cambridge, MA) in medium RPMI 1640 (Biofluids, Rockville, MD) supplemented with 10% fetal bovine serum, 2 mM t-glutamine, 0.05 mM 2-ME, 50 /~g/ml penicillin, and 50/~g/ml streptomycin. LPS was added to some cultures at 20 Izg/ml, was added to some cultures at 10,000 U/ml, and anti-IFN-3' mAb (XMG-6) was added to some cultures at 5 #g/ml.
Quantitation oflg Isotypes. Serum IgG1 and IgG2a were quantitated by radial immunodiffusion, using rabbit anti-mouse IgG1 antiserum (30) and a sheep anti-mouse IgG2a antiserum purchased from The Binding Site, Ltd. (Birmingham, UK). IgG1 and IgG2a in culture supernatants, and IgE in serum and in culture supernarants, were quantitated by ELISA (31) .
Quantitation of Cytokine mRNA. A reverse transcriptase-PCR approach (32) was used to determine relative quantities of mRNA for Ib4 and IFN-3' (details below). This approach has been shown to reproducibly detect less than 1.3-fold differences in mRNA content.
Isolation and Purification of RNA. ILNase-free plastic and water were used throughout the assay. Tissues were homogenized in RNAzol (Cinna/Biotecx, Friendswood, TX) at 50 mg of spleen per ml. 0.2 ml of chloroform was added per 2 ml of homogenate, the samples were tightly covered, shaken vigorously for 15 s, and then incubated on ice for 15 min. The suspension was centrifuged at 12,000 g (4~ for 15 min. The aqueous phase was transferred to a fresh tube, to which an equal volume of isopropanol was added. After mixing, the samples were incubated for 45 min at -200C. Samples were centrifuged for 15 min at 12,000 g (4~ The resultant tLNA precipitate was transferred to a 1,2 ml centrifuge tube and washed twice with 75% ethanol. The final preparation was suspended in water and quantitated spectrophotometrically.
To ascertain whether the RNA was intact and whether the concentration had been determined correctly, the purified RNA (10 #g) was electrophoresed on a 2% formaldehyde gel containing ethidium bromide (33) . The gel was photographed and individual lanes were examined for the presence of the 18S and 28S ribosomal bands, the absence of RNA degradation, and whether equal loading of RNA on each lane had occurred.
Reverse Transc@tase Reaction. The coupled reverse transcription/polymerase chain reaction used here was a modification of that described by Diamond et al. (34) . Reverse transcription of RNA was performed in a 25/xl final volume containing: (a) 2.5/xl of a 10 mM mix of all four deoxynucleotide triphosphates (dNTP); for 5 min to denature the RNA, cooled on ice and 1.2 #1 of reverse transcriptase (RT) (200 U/ml) was added. This was again mixed, centrifuged to pellet any precipitate, and incubated at 37~ for 60 rain. The reaction was next heated at 90~ for 5 min, then quickly cooled on ice.
Polyraerase Chain Reaction. The primers for amplification during the PCR have been described (32) . Product amplified from cDNA could be distinguished from any amplified from genomic DNA, because the primers amplified genomic DNA introns as well as exons. To the 12 #1 of KT mix the following components were added: (a) 4 #1 dNTP mix (10 mM); (b) 5 #1 10x PCR buffer (500 mM KCI, 100 mM Tris-HC1, 15 mM MgC12, 1 mg/ml BSA); (c) 5 #1 sense primer (0.2 #g/#l); (d) 2 #1 anti-sense primer (0.2 #g/ml); (e) 24 #1 double distilled H20; (f) 0.5 #1 Taq polymerase (5 U/ml). After an initial incubation at 95~ for 5 rain, temperature cycling was initiated with each cycle as follows: (a) 95~ for 1 min (denaturation); (b) 53-55~ (depending on the cytokine to be amplified) for 1 min (annealing of primers); (c) 72~ for 3 min (primer extension). For each gene product, the optimum number of cycles was determined experimentally, and was defined as that number of cycles that would achieve a detectable concentration which was well below saturating conditions.
To verify that equal amounts of RNA were added in each PCR reaction within an experiment and to verify a uniform amplification process, hypoxanthine-guanine phosphoribosyl transferase (HPRT) mRNA was also reverse transcribed and amplified for each assay (32) .
Detection of the Amplified Product by Southern Blot Analysis. 10
#1 of the final reaction mix was run on a 1% agarose gel at 120 volts for 3 h. The gel was then denatured by soaking for 45 rain in several volumes of 1.5 M NaC1, 0.5 N NaOH with constant, gentle agitation. The gel was then rinsed briefly in deionized water, and neutralized by soaking for 45 rain in several volumes of I M Tris (pH 7.4), 1.5 M NaCI at room temperature with constant agitation. The DNA was then transferred to a nylon membrane by standard blotting procedures (35) . The membrane was UV crosslinked using the UV Stratalinker 1800 (Stratagene, La Jolla, CA). Blots were prehybridized at 42~ for 6 h in a solution containing 6x SSPE and 1% SDS. The probes were specifically selected to hybridize to a portion of the amplified segment between the nucleotide sequences complementary to the primers. This ensured the identity of the segment amplified. After hybridization, blots were washed for 15 rain in 6x SSPE, 0.1% SDS and then 3-4 rain in 2 x or lx SSPE at 49~ Autoradiographs were exposed at -70~ using Kodak XAR-2 film.
Video Densitometry. Following autoradiography, the resultant bands on the XAR-2 film represent areas of specific probe hybridization. The band intensity was quantitated using one of two methods: (a) With the JAVA video densitometry system (Jandel Scientific, Corte Madera, CA), several autoradiographic exposures were taken of each blot to ensure that the signal from each band was in the linear range of the film response. (b) Blots were exposed to a phosphor screen that was then read directly with a 400 series phosphoimager (Molecular Dynamics, Sunnyvale, CA). The high sensitivity and broad dynamic range of the phosphoimager facilitated quantitation.
Results

Effect of lFN-ol on Increases in Serum Immunoglobulin (Ig) Levels and Spleen Weight in CaM&injected Mice.
To determine the effect of recombinant mouse IFN-o~ on the humoral immune response to GaMe, mice were injected i.v. with 800 #g of GaM~ and 2, 3, and 4 d later were injected twice daily i.p. with 0.2 ml of 0.5 M NaC1/0.02 M Tris, pH 7.4, or with the same buffer containing 1, 5, or 25 #g of rlFN-c~. Analysis of sera obtained 8 d after GaM~ injection indicated that GaM~ stimulated an approximately 15-fold increase in serum IgG2a and a greater than 100-fold increases in serum IgG1 and IgE levels (Fig. 1) . In addition, an approximately five-fold increase in spleen weight was observed in GaM6-injected mice. IFN-oc at the highest dose tested, suppressed serum IgE levels by greater than 90% and IgG1 levels by approximately 60%, while enhancing serum IgG2a levels twothree-fold, but had no effect on spleen weight. To determine if any of these effects were dependent upon the presence of IFN-% additional groups of mice that were injected with both GaM~ and 1 rag of anti-IFN-3, mAb were similarly treated with buffer or IFN-c~. In the absence of IFN-oe, anti-IFN-3, enhanced the GaM#-induced IgG1 and IgE responses and suppressed the GaM/~-induced IgG2a response. IFN-c~ strongly suppressed the IgE response and stimulated the IgG2a response in these mice, but had no effect on the IgG1 response. Thus, IFN-o~, independently of IFN-T, can inhibit IgE production and enhance IgG2a production, but has no independent effect on the IgG1 response. The effects of IFN-ol on Ig isotype secretion were not simply the result of altered kinetics of Ig secretion. When administered on days two through four after GaM~ injection, IFN-c~ enhanced serum IgG2a levels and inhibited serum IgE levels both 8 and 10 d after GaM/~ treatment (Fig. 2) . However, a large day 8 to day 10 decrease in serum IgE levels was seen in GaM/~-treated mice, while IgE levels remained at a low, but stable level in mice that also received IFN-ot.
IFN-cr Has an Early Suppressive Effect on the Generation of an IgE Response in GaM&injected Mice. Previous studies have
demonstrated that a 3-d course of IFN-3, has its greatest suppressive effect on IgE secretion by GaM/~-injected mice if administered 2 through 4 d after GaM/~ injection (7). To determine if IFN-c~ suppression of the IgE response followed the same kinetic pattern, GaM/t-treated mice were injected twice daily with IFN-ot on the day of and on the 2 d following GaM/~ injection, or on days 2 through 4 after GaM/k In this experiment, a suboptimal dose of IFN-ot was used (10/zg twice a d), so that minor time-related differences in IFN-ot suppression of IgE production could be optimally detected, and all mice were treated with anti-IFN-3, mAb, to eliminate any effects of this cytokine on the IgE response. Sera were obtained 8 d after GaMe5 injection and serum Ig levels were measured. Treatment with IFN-a, on the day of and on the 2 d following GaM8 injection, or on days 2 through 4 after GaMe5, decreased serum IgE levels by a factor of approximately three, and had no significant effect on IgG1 levels (data not shown).
Endogenous IFN~/~ Production Suppresses IgE Secretion. To
investigate the possibility that endogenously produced IFN-o~ or IFN-3 could effect Ig isotype selection in the same way as injected recombinant IFN-o~, we studied the effects of injecting poly I.C, a potent inducer of endogenous IFN-od~ production (36) (37) (38) , on the immune responses induced by GaM/L Mice in this experiment also received anti-IFN-3, mAb, because we have found that poly I.C can induce the production of IFN-y as well as IFN-ot/3 (Snapper, C.M., H. Yamaguchi, J.F. Urban, Jr., and F.D. Finkelman, manuscript submitted for publication). Injection of a single dose of poly I.C (100/~g i.p.) on the day of or 1 or 2 d after GaM/~ suppressed the GaMe-induced IgE response by approximately 90%, but had no suppressive effect on serum IgG1 levels (data not shown).
Since poly I.C has important biological effects in addition to the induction of IFN production, it was possible that the effects of poly I-C on Ig isotype regulation were unrelated to its stimulation of an IFN-ol response. To determine the relationship between the poly I.C effects and IFN-a (or IFN-B) production, we studied the ability of a sheep anti-IFNc~/fl antiserum to block the effects of poly I.C on Ig isotype selection in anti-IgD antibody-treated mice. In these experiments, a pair of mouse IgG2 antibodies of the b allotype that are specific for IgD of the a allotype (H#'/1 and FF1-4D5, abbreviated as MaM6) were used instead of GaMe. Because poly I.C rapidly stimulates macrophage production of IFN-oe, mice were injected with anti-IFN-ot//5 antiserum and anti-IFN-3, mAb 1 d before their injection with the anti-/~ mAbs and poly I.C. In mice pre-treated with anti-IFN-3, mAb plus a control sheep serum, a 200/zg dose of poly I-C inhibited the IgE response induced by MaM~ by greater than 90% (Fig.  3) . No inhibition of the IgE response by poly I.C was observed, however, when mice were pretreated with sheep anti-IFN-c~/3 rather than with the control sheep serum. In contrast, serum IgG2a levels were approximately twice as high in mice treated with MaMa, poly I.C, and anti-IFN-qr mAb in the presence of control sheep serum as in mice injected with the same agents in the presence of sheep anti-IFN-cff3 antiserum (Fig. 3) . As expected, neither poly I-C nor anti-IFN-oE/~ antiserum had a significant effect on the IgG1 response induced by MaM/~ in the presence of anti-IFN-3' mAb. These observations demonstrate that the effects of poly I.C on Ig isotype selection in anti-/~ plus anti-IFN-3, antibody treated mice, which closely resemble the effects of recombinant IFN-ol, result from the stimulation of endogenous IFN-oe and/or IFN-B production. determined by ELISA (Fig. 4) . At a concentration of 10 U/ml, IFN-ot had no effect on the LPS-induced IgG2a response or the LPS + IL-4-induced IgG1 response, and inhibited the LPS + IL-4-induced IgE response by a factor of 2 (Fig. 4,  upper panel) . Increasing the concentration of IFN-ot to 1,000 U/ml increased inhibition of the LPS + IL-4-induced IgG1 and lgE responses to factors of 3 and 4, respectively, but still had no significant effect on the LPS-induced IgG2a response. In contrast, IFN-3' at a concentration of 10 U/ml inhibited the LPS + Ib4-induced IgG1 and IgE responses by factors of 70 and 12, respectively, and enhanced the LPS-induced IgG2a response by a factor of 8 (Fig. 4, lower panel) . Addition of anti-IFN-y mAb to cultures inhibited the effects of IFN-% but not those of IFN-ot (data not shown). Similar observations were made in additional in vitro experiments. Enhances IFN-'y mRNA Levels in Anti-c5 Antibodytreated Mice. The weak and similar inhibitory effects of IFN-c~ on IgG1 and IgE responses in an in vitro system, and the lack of a stimulatory effect of IFN-c~ on IgG2a production in this system, as compared to IFN-oe's strong in vivo inhibition of IgE, but not IgG1 production, and stimulation of IgG2a production, suggested that IFN-oe might indirectly inhibit in vivo IgE secretion by inhibiting the production of IL-4. This would be consistent with the observation that although II.-4 costimulates both IgG1 and IgE production and inhibits IgG2a production in vitro (8-11), anti-Ib4 and anti-IL-4 receptor mAbs completely block IgE production and enhance IgG2a production, but have little effect on IgG1 production in GaMes-injected mice (12, 13) . To investigate whether IFN-ot might selectively modulate the production of IL-4 in vitro, Figure 5 . IFN-c~ inhibits the GaMe-induced increase in splenic IL-4 mRNA levels and enhances the increase in splenic IFN-3, mRNA levels. BALB/c mice (5/group) were left untreated or were injected i.v. with 100/zg each of two anti-5 mAbs (HSa/1 and FF1-4D5), and 1 mg each of anti-Fcq, RII mAb (24G2) and anti-IFN-3, mAb (XMG-6). Some mice also were injected i.p. with 25,000 U of recombinant mouse IFN-o~, twice daily, on the day of and 1 and 2 d after antibody administration. Two additional groups of mice that received the mAb cocktail were injected at the same time i.p. with 200/~g of poly I.C; one group was pretreated 1 d earlier with 0.2 ml of sheep anti-mouse IFN-a/B antiserum, the other group with a control sheep serum, mRNA was prepared from spleens 4 d after mAb injection, cDNA was prepared from mRNA and amplified with primers specific for Ib4 or IFN-~/DNA, as described in Materials and Methods, subjected to electrophoresis, and hybridized with specific probes by the Southern blot technique. The blots were exposed to phosphor screens and the resulting images were analyzed with a Molecular Dynamics phosphoimager.
IFN-cr/~ Has a Relatively Modest Effect on lmmunoglobulin (Ig) Isotype Secretion in Vitro by Lipopolysaccharide (LPS)-activated
IFN-oL Inhibits Splenic Interleukin (IL)-4 mRNA Levels and
we used a reverse transcriptase-PCR technique (32) to quantitate splenic II-4 and IFN-y mRNA levels in mice injected with MaM6 antibody plus anti-IFN-~/mAb in the presence or absence of recombinant mouse IFN-ct. Levels were determined 4 d after anti-IgD antibody injection, because previous studies have shown that both cytokine genes are expressed at this time (32) and that both II-4 and IFN-'y have an important effect at this time on Ig isotype selection (7, 39) . Injection of mice with a combination of MaMa, anti-FcTRII mAb, and anti-IFN-3, mAb induced 34-and 4-fold increases in the expression of splenic I1-4 and IFN-3r mKNA, respectively (Fig. 5) , but had no effect on HPKT mRNA levels (data not shown). (Fig. 5) . Poly I.C stimulated an approximately nine-fold increase in IFN-~ gene expression, regardless of whether mice were pretreated with anti-IFN-ol/3 or control antiserum. This is consistent with our previous observation that poly I.C directly stimulates IFN-3,, as well as IFN-oz secretion (Snapper, C.M., H. Yamaguchi, J.F. Urban, Jr., and F.D. Finkdman, manuscript submitted for publication).
Discussion
The discoveries that two cytokines, IL-4 and IFN-% can have striking, and usually opposite effects on Ig isotype selection (1, 2, 11) , and that normal CD4 + T cells and T cell clones can differ markedly in their relative secretion of these two cytokines (3), raised two additional questions: (a) Are there additional cytokines that regulate Ig isotype sdection? and (b) What regulates the differentiation of virgin, resting CD4 + T cells into effector calls that secrete high or low ratios of Ib4/IFN-7. The data presented in this paper make it likely that IFN-a (and presumably, IFN-3), is in the group of cytokines that regulates Ig isotype selection indirectly by decreasing the ratio of IL-4/IFN-',/that is secreted by T cells as well as through a direct effect on B cells. This interpretation is supported by observations that: (a) recombinant IFN-ce inhibits IgE secretion and enhances IgG2a secretion when injected into anti-IgD antibody-injected mice; (b) these effects are not IFN-'y dependent, since they are observed in mice injected with an anti-IFN-3, mAb; (c) the effect of IFN-c~ is mimicked by poly I.C, which stimulates endogenous IFN-c~ secretion; (d) a sheep antiserum, that neutralizes IFN-cz and IFN-3, blocks the Ig isotype modifying effects of poly I.C in mice stimulated with a combination of anti-IgD and anti-IFN-3/mAbs; (e) IFN-c~ is considerably less potent than IFN-3/in its inhibition of IgG1 and IgE production by LPS + IL-4-stimulated B ceUs in vitro, and, unlike IFN-% has no ability to enhance IgG2a production by LPS-activated B ceils; and (f) IFN-a treatment of anti-IgD antibody-treated mice decreases the splenic level of IL-4 mRNA but increases the level of splenic IFN-3/mRNA. The observation that IFN-ot inhibits in vivo IgG1 production in the absence of anti-IFN-7 mAb, but has no effect on IgG1 production in the presence of anti-IFN-7 mAb, suggests that the in vivo effect of IFN-cz on this isotype is entirely due to the stimulation of increased IFN-3' production.
Our overaU interpretation must be made, however, with some caveats: (a) Anti-IgD antibody is an atypical immunogen. It binds to, and is processed and presented to T cells by, the majority of B ceils, with the result that T cell activation and cytokine secretion are greatly enhanced as compared to the levels that are usually observed during a response to a conventional T cell-dependent antigen. This large degree of T cell activation contributes to the generation of an enormous Ig response in anti-IgD antibody-treated mice 0 0' 31). While these peculiarities of the anti-IgD antibody system make it ideal for the detection of cytokine effects on Ig isotype and cytokine gene expression, there is no assurance that IFN-cz will have the same effects in responses to conventional antigens that it has in anti-IgD antibody-injected mice. It is reassuring, however, that the effects of IFN-7 and Ib4 on Ig isotype selection that were initially observed in GaM/~ antibody-injected mice have since been confirmed in other systems (2) . (b) Since no mAbs that potently neutralize both IFN-a and IFN-fl are available, it was necessary to use a polyclonal sheep anti-IFN-a/fi antibody in studies performed to demonstrate that the effect of poly I.C on Ig isotype selection resulted from IFN-ot/fl production. Since this sheep antibody was prepared against purified natural mouse IFN-ol and IFN-fl, it is impossible to be completely certain that it does not have some ability to neutralize cytokines in addition to IFN-ot/3. Tests have demonstrated, however that it lacks anti-II.-2, IFN-% or TNF antibody activity. (c) Our observation that IFN-oe treatment inhibits splenic IL-4 mRNA levels, and enhances IFN-3, mRNA levels, demonstrates that IFN-ot differentially regulates cytokine gene expression. It does not, however, prove that IPN-cz modifies the secretion of these cytokines to the same extent, since protein synthesis and secretion may be at least partially controlled at translational or posttranslational levels. (d) In as much as we havre quantitated mRNA levels in unfractionated spleen cells, we cannot identify with certainty the call population or populations in which IFN-a affected IL-4 and IFN-3, gene expression. It seems likely, however, that the effects observed were predominantly in CD4 + T ceUs, since T cells are the only cells in GaM/~-treated mice that secrete detectable Ib4 (40) and since CD4 + spleen cells from these mice contain greater than 100-fold more IL-4 encoding mRNA than do CD4-spleen cells (32) .
Our interpretation draws support from the observation that most viruses, which induce the production of large quantities of IFN-cc/fl as well as IFN-% induce the production of IgG2a as their predominant Ig isotype (41) . Studies are currently being performed to determine the relative contributions of IFN-odfl and IFN-7 to IgG2a predominance in these mice. A role for IFN-a/3 in the determination of T cell differentiative pathways is also compatible with results of investigations of mice infected with the protozoan parasite Leishmania major. T ceUs of BALB/c mice infected with this parasite secrete a high ratio of IL-4/IFN-% while T cells of Leishmania-infected C57BL/6 mice secrete a high ratio of Ib4/IFN-~ ratio (6) . This difference in cytokine secretion is at least partially responsible for the progressive disease observed in BALB/c mice, as opposed to the limited disease seen in C57BL/6 mice, as well as for the expected differences in the Ig isotypes secreted by these different mouse strains (5, 6) . Interestingly, macrophages from BALB/c mice produce much less IFN-ee than do C57BL/6 macrophages, when stimulated with agents such as poly I.C (42) . Experiments are being performed to determine whether this correlation is fortuitous or reflective of an importarlt control mechanism in the establishment of different T cell cytokine secretory patterns.
IFN-ot is not the only factor that can influence the ratio of ID4/IFN-3~ secretion by T lymphocytes. IFN-7 inhibits the proliferation of T cell clones that secrete II~4, IL-5, and IL-10 (Th2 cells) but not the proliferation of T cell clones that secrete Ib2 and IFN-3' (Thl ceils) (15) . Ibl0 inhibits cytokine production by Thl, but not by Th2 cells (16) . Neither IFN-3' nor ILl0, however, has yet been shown to influence the differentiation of uncommitted, resting T cells in vitro or to influence T cell cytokine production in vivo. In contrast, while IL-4 has not been shown to affect cytokine secretion by established Thl or Th2 cells, it promotes the differentiation of T cells into Ib4-secreting cells in some in vitro systems, and appears to directly or indirectly promote IL4 secretion and inhibit IFN-~ secretion in some in vitro and in vivo systems (43) (44) (45) (46) .
IFN-oe differs from Ib4, IL-10, and IFN-3' in that it is produced predominantly by non-T cells, and especially by a cell type, the macrophage (37, 38) , that has an important role in the presentation of antigen to T cells. Thus, the capacity of an antigen to stimulate macrophage production of IFN-ce, which can occur soon after macrophage and antigen first come into contact, may allow virgin T cells to simultaneously be presented with processed antigen, that leads to their activation, plus a cytokine that induces them to differentiate in a Thl direction. However, while II.-4, II:10, and IFN-y appear to be produced predominantly by T cells, their production by other cell types has also been described. We would propose that B cell production of I1:10 (47), NK cell production of IFN-3, (48), mast cell or basophil production of I1:4 (49) (50) (51) , and the presumed production of other cytokines by non-T cells early in the course of an immune response may, like macrophage production of IFN-o~, act to influence the direction of T cell differentiation. This hypothesis would suggest that auxiliary properties of antigens, that lead to their stimulation of specific cytokines by non-T cells, rather than the expression of specific T cell epitopes, regulates differential T cell cytokine production.
